{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:37:42Z","timestamp":1788845862706,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.amjms.2025.09.007","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T15:37:46Z","timestamp":1757605066000},"page":"82-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A multiple sclerosis review for the primary care physician"],"prefix":"10.1016","volume":"371","author":[{"given":"William","family":"Meador","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.amjms.2025.09.007_bib0001","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.amjms.2025.09.007_bib0002","article-title":"Comparison of pharmacological therapies in relapse rates in patients with relapsing-remitting multiple sclerosis","volume":"15","author":"Etta","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.amjms.2025.09.007_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ene.15593","article-title":"Diagnosis and treatment of progressive multiple sclerosis: a position paper","volume":"30","author":"Pozzilli","year":"2023","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.amjms.2025.09.007_bib0004","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.amjms.2025.09.007_bib0005","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/WCO.0000000000000622","article-title":"Multiple sclerosis: clinical aspects","volume":"31","author":"Oh","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.amjms.2025.09.007_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1004795","article-title":"Anti-CD20 therapies in multiple sclerosis: from pathology to the clinic","volume":"14","author":"de S\u00e8ze","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.amjms.2025.09.007_bib0007","first-page":"527","article-title":"Progressive multiple sclerosis: from pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2016","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.amjms.2025.09.007_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12010006","article-title":"Recommendations for the diagnosis and treatment of multiple sclerosis relapses","volume":"12","author":"Ramo-Tello","year":"2021","journal-title":"J Pers Med"},{"issue":"12","key":"10.1016\/j.amjms.2025.09.007_bib0009","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.purol.2020.10.011","article-title":"Prevalence of comorbidities in multiple sclerosis patients with neurogenic bladder","volume":"31","author":"Declemy","year":"2021","journal-title":"Prog Urol"},{"issue":"10","key":"10.1016\/j.amjms.2025.09.007_bib0010","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrneurol.2015.157","article-title":"Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis\u2013establishing disease prognosis and monitoring patients","volume":"11","author":"Wattjes","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.amjms.2025.09.007_bib0011","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis \u2013 a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.amjms.2025.09.007_bib0012","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes","year":"2021","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.amjms.2025.09.007_bib0013","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/135245859900500203","article-title":"Survey of multiple sclerosis in northern California. Northern California MS Study Group","volume":"5","author":"Goodin","year":"1999","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.amjms.2025.09.007_bib0014","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1590\/s1677-5538.ibju.2021.0098","article-title":"Neurogenic bladder - concepts and treatment recommendations","volume":"48","author":"Truzzi","year":"2022","journal-title":"Int Braz J Urol"},{"issue":"4","key":"10.1016\/j.amjms.2025.09.007_bib0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.pmr.2013.07.003","article-title":"Spasticity management in Multiple sclerosis","volume":"24","author":"Hughes","year":"2013","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"1","key":"10.1016\/j.amjms.2025.09.007_bib0016","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ncl.2023.06.007","article-title":"Health, wellness, and the effect of comorbidities on the Multiple sclerosis disease course: tackling the modifiable","volume":"42","author":"Conway","year":"2024","journal-title":"Neurol Clin"},{"key":"10.1016\/j.amjms.2025.09.007_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1197195","article-title":"Etiology, effects and management of comorbidities in multiple sclerosis: recent advances","volume":"14","author":"Marrie","year":"2023","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.amjms.2025.09.007_bib0018","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamaneurol.2015.4807","article-title":"Immunologic effects of Metformin and Pioglitazone treatment on metabolic syndrome and multiple sclerosis","volume":"73","author":"Negrotto","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.amjms.2025.09.007_bib0019","article-title":"Late-onset epilepsy","author":"Rakis","year":"2022","journal-title":"Pract Neurol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925011851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925011851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T14:33:40Z","timestamp":1767796420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925011851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0002962925011851"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.09.007","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multiple sclerosis review for the primary care physician","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}